Gaslight 👻
11.4K posts

Gaslight 👻
@RetailGaslight
I like health and fitness I like bioenergetics I like making money in liquid markets Follow me for the worst controlled N=1 experiments you've ever seen








I would be curious for someone to run industrial solvent testing on RUO peptides given that SPPS involves dichloromethane (DCM) and N,N-dimethylformamide (DMF). Doesn’t mean they’re in RUO peptides but until we see some tests get done, we just won’t know.




A white lady provokes innocent & peaceful people calling them the "n" word 😳😱😱











People often pair MOTS-c alongside metabolic compounds like retatrutide. This could make sense, biologically. Retatrutide is known to help curb appetite and enhance blood sugar control, while MOTS-c has been researched for its potential to aid muscles in utilizing glucose. Another possible connection is fat metabolism. Reta’s glucagon activity is tied to higher energy expenditure and changes in how the body uses fat, which fuels mitochondrial energy production.





A new shot literally regrows knee cartilage. Researchers at Stanford Medicine have identified a novel strategy to regenerate articular cartilage in knees and potentially prevent or treat osteoarthritis (OA). The method targets 15-hydroxyprostaglandin dehydrogenase (15-PGDH), an age-related enzyme—or "gerozyme"—that accumulates in aging tissues and drives degeneration. In aged mice, small-molecule inhibitors of 15-PGDH, delivered systemically or via intra-articular injection, promoted cartilage thickening and regeneration of functional hyaline articular cartilage. This occurred without recruiting stem or progenitor cells; instead, existing chondrocytes underwent transcriptional reprogramming to a youthful state, with reduced populations of inflammatory and hypertrophic/degradative cells and expanded matrix-producing articular chondrocytes. The inhibitors also reversed natural age-related cartilage thinning, improved joint function, and—when administered after simulated ACL injuries—strongly mitigated post-traumatic OA progression and associated pain. Human OA cartilage explants from total knee replacements responded similarly in vitro, showing decreased degradation markers and evidence of new articular cartilage formation. Given that an oral 15-PGDH inhibitor has already completed Phase 1 safety trials for age-related muscle atrophy, the findings open a path toward disease-modifying, regenerative therapies that could delay or obviate the need for joint replacement surgery. [Agarwal, P., Su, S., Ancel, S., et al. (2025). Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration. Science. DOI: 10.1126/science.adx6649]




have been saying this. most extra tests are marketing grifts. your peptide doesn’t have heavy metals or fentanyl, as long as its reported quantity and purity is on the mark (+/- 10% on quantity and above 99% purity) as well as endotoxins/sterility pass, nothing else matters.








